In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium.

Department of Psychiatry and Behavioral Sciences, Emory Center for Positron Emission Tomography, Atlanta, Ga, USA.
The Journal of Clinical Psychiatry (Impact Factor: 5.14). 02/2000; 61 Suppl 9:41-6.
Source: PubMed

ABSTRACT The therapeutic efficacy of lithium for the long-term management of bipolar disorder is well recognized, along with the risk of lithium-induced toxicity. The author describes the current findings of in vivo functional neuroimaging techniques with respect to the pharmacokinetics and pharmacodynamics of lithium and their future potential to elucidate the drug distribution and neural mechanisms that produce its therapeutic effects. Brain Li nuclear magnetic resonance spectroscopy findings have disassociated postdose brain and blood lithium concentrations and suggest a pharmacokinetic basis for lithium response and nonresponse. The application of in vivo synaptic activity and neurochemical imaging is providing new knowledge related to the distributed neural activity associated with lithium response and is contributing to the critical human testing of neuroprotective and signal transduction models of lithium's therapeutic effects.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The authors' goal was to determine if there is an association between brain-to-serum lithium ratios and age. Lithium-7 magnetic resonance spectroscopy was used to measure in vivo brain lithium levels in nine children and adolescents (mean age=13.4 years, SD=3.6) and 18 adults (mean age=37.3, SD=9.1) with bipolar disorder. Serum and brain lithium concentrations were positively correlated. Younger subjects had lower brain-to-serum concentration ratios than adults: 0.58 (SD=0.24) versus 0.92 (SD=0.36). The brain-to-serum concentration ratio correlated positively with age. These observations suggest that children and adolescents may need higher maintenance serum lithium concentrations than adults to ensure that brain lithium concentrations reach therapeutic levels.
    American Journal of Psychiatry 08/2002; 159(7):1240-2. DOI:10.1176/appi.ajp.159.7.1240 · 13.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Social anxiety disorder is a common, chronic and often debilitating condition. Selective serotonin reuptake inhibitors have been widely used for the treatment of anxiety disorders, with more data currently available for paroxetine. With its beneficial side-effect profile and proven efficacy in social anxiety disorder, sertraline can be considered a valuable addition to the variety of treatments currently available for this disorder.
    Expert Review of Neurotherapeutics 11/2003; 3(6):787-95. DOI:10.1586/14737175.3.6.787 · 2.83 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The biomedical applications of 7Li MRS and MRI have been progressing slowly. The interest derives primarily from the clinical use of Li to treat bipolar disorder. One area of concern is the nature of ionic transport and binding, so as to elucidate the mechanism(s) of therapeutic action and toxicity. Another is the development of a non-invasive, in vivo analytical tool to measure brain Li concentration and environment in humans, both as an adjunct to treatment and as a mechanistic probe. Here we review the most recent progress toward these goals.
    NMR in Biomedicine 04/2005; 18(2):67-73. DOI:10.1002/nbm.914 · 3.56 Impact Factor
Show more


Available from